PROJECT SUMMARY/ABSTRACT – PROJECT 2 Exposure of people to single chemicals or mixtures at Superfund sites has unquestionably occurred. The unanswered question addressed here is whether those exposures can be associated with measurable risks to genome integrity or expression, which would provide biological plausibility to the argument that the chemicals in the environment have affected human health and welfare. The compounds chosen for investigation were inspired by engagement efforts with a local community containing a Superfund site and with Tribal groups in Maine. Carcinogenic N-nitrosamines (e.g., N-nitrosodimethylamine or NDMA) as well as other toxicants are abundant in both of our catchment areas. These agents have not been studied as mutagens or proteome disruptors at the level of detail proposed here, and they certainly have not been subjected to the combined multi-omic scrutiny of this Project taken together with Project 1 (DNA damage and gene-environment interactions). The technology of Project 2 has five components: (a) We employ a genetically engineered panel of mice (Project 1) that responds to environmental toxicants in a manner that reveals underlying mechanisms that confer susceptibility to a toxicant. The pathway to toxicity involves disease initiation, concomitant complications such as tissue-destructive inflammation, through end stage pathologies such as cancers. (b) We use a newly developed high-fidelity DNA sequencing procedure that provides unprecedentedly high-resolution mutational spectra (HRMS); HRMS can be used to identify chemical-specific mutational patterns resulting from environmental exposures. (c) We use a unique proteomic platform that sensitively senses disruptions in thousands of nodes in signaling networks. (d) We use a novel computational module via the Data Management and Analysis Core that quantitatively compares HRMS and proteomic patterns from our models with the rapidly expanding human data sets of The Cancer Genome Atlas Project (TCGA), other tumor sequencing efforts, and the growing body of knowledge of proteomic patterns. (e) Lastly, we introduce mouse embryo fibroblast (MEF) lines isogenic with our mouse models that can be used as high-throughput screening tools to help find genotoxic fractions in complex mixtures (Projects 3 and 4). Our multi-omic approach centers on animal and cellular models, but we also look ahead to application of these novel tools for molecular epidemiology and for disease prevention. Regarding the latter possibility, the proteomic and mutagenic biomarkers we already see in our work can be immediately be used to assess the efficacy of probiotic mitigation of disease, via our interactions with Project 1. Regarding contributions to epidemiology, the distinctive mutational spectra we have already observed following NDMA exposure to animals and cells could eventually become valuable early-onset biomarkers that portend later life diseases. Taken together, this Project leverages basic...